A study to investigate changes in the levels of biomarkers of exposure to selected cigarette smoke constituents in Japanese adult male smokers who switched to a non-combustion inhaler type of tobacco product

Regulatory Toxicology and Pharmacology

Volumn 71, Issue 3, 2015, Pages 498-506

  Miura, Naoki ^a   Yuki, Dai ^a   Minami, Naoki ^a   Kakehi, Aoi ^a   Futamura, Yasuyuki ^a  

^a JAPAN TOBACCO INC   (Japan)

Author keywords

Biomarkers; Cigarette; Clinical study; Exposure; Smokeless tobacco; Smoking

Indexed keywords

1,3 BUTADIENE; 4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; 4 BIPHENYLAMINE; ACROLEIN; BENZENE; BENZO[A]PYRENE; BIOLOGICAL MARKER; CARBON MONOXIDE; CROTONALDEHYDE; HYDROGEN CYANIDE; NICOTINE; PYRENE; TAR; MUTAGENIC AGENT; SMOKE;

ADULT; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; HALF LIFE TIME; HUMAN; HUMAN EXPERIMENT; INTERMETHOD COMPARISON; JAPANESE (PEOPLE); MALE; MUTAGEN TESTING; NON COMBUSTION INHALER TYPE TOBACCO; NORMAL HUMAN; OPEN STUDY; PARALLEL DESIGN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SMOKELESS TOBACCO; SMOKING; URINALYSIS; ADVERSE EFFECTS; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; JAPAN; MIDDLE AGED; MULTICENTER STUDY; RISK ASSESSMENT; SMOKE; TIME; TOBACCO; URINE; YOUNG ADULT;

NICOTIANA TABACUM;

ADULT; BIOMARKERS; BLOOD CHEMICAL ANALYSIS; HUMANS; JAPAN; MALE; MIDDLE AGED; MUTAGENICITY TESTS; MUTAGENS; RISK ASSESSMENT; SMOKE; SMOKING; TIME FACTORS; TOBACCO PRODUCTS; TOBACCO, SMOKELESS; URINALYSIS; YOUNG ADULT;

EID: 84923936560     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2015.02.007     Document Type: Article

References (22)

1. Buchhalter A.R., Eissenberg T. Preliminary evaluation of a novel smoking system: effects on subjective and physiological measures and on smoking behavior. Nicotine Tob. Res. 2000, 2:39-43.
2. Doolittle D.J., Rahn C.A., Burger G.T., Lee C.K., Reed B., Riccio E., Howard G., Passananti G.T., Vesell E.S., Hayes A.W. Effect of cooking methods on the mutagenicity of food and on urinary mutagenicity of human consumers. Food Chem. Toxicol. 1989, 27:657-666.
3. Goniewicz M.L., Havel C.M., Peng M.W., Jacob P., Dempsey D., Yu L., Zielinska-Danch W., Koszowski B., Czogala J., Sobczak A., Benowitz N.L. Elimination kinetics of the tobacco-specific biomarker and lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol. Cancer Epidemiol. Biomarkers Prev. 2009, 18:3421-3425.
4. Health Canada Determination of ''Tar", Nicotine and Carbon Monoxide in Mainstream Tobacco Smoke-Official Method 1999, Health Canada, Ottawa, (SOR-2000-272).
5. Hecht S.S., Carmella S.G., Chen M., Dor.Koch J.F., Miller A.T., Murphy S.E., Jensen J.A., Zimmerman C.L., Hatsukami D.K. Quantitation of urinary metabolites of a tobacco-specific lung carcinogen after smoking cessation. Cancer Res. 1999, 59:590-596.
6. Tobacco smoke and involuntary smoking. IARC Monogr. Eval. Carcinog. Risks Hum. 2004, 83:1-1438. International Agency for Research on Cancer.
7. International Agency for Research on Cancer Smokeless tobacco and some tobacco-specific N-nitrosamines. IARC Monogr. Eval. Carcinog. Risks Hum. 2007, 89:1-592.
8. International Organization for Standardization, 2000. Routine analytical cigarette-smoking machine, ISO3308.
9. Institute of Medicine Scientific Standards for Studies on Modified Risk Tobacco Products 2012, The National Academy Press, Washington DC.
10. Junge B. Changes in serum thiocyanate concentration on stopping smoking. Br. Med. J. (Clin. Res. Ed.) 1985, 291:22.
11. Kado N.Y., Langley D., Eisenstadt E. A simple modification of the Salmonella liquid-incubation assay. Increased sensitivity for detecting mutagens in human urine. Mutat. Res. 1983, 121:25-32.
12. Kado N.Y., Manson C., Eisenstadt E., Hsieh D.P. The kinetics of mutagen excretion in the urine of cigarette smokers. Mutat. Res. 1985, 157:227-233.
13. Miura N., Yuki D., Minami N., Kakehi A., Onozawa M. Pharmacokinetic analysis of nicotine when using non-combustion inhaler type of tobacco product in Japanese adult male smokers. Regul. Toxicol. Pharmacol. 2013, 67:198-205.
14. Okuzono H., Tamagawa S., Hattori S. A spectrophotometric method for the determination of carboxyhemoglobin in blood, and some clinical reports. Rinsho Byori. 1976, 24:616-621.
15. Pérez-Stable E.J., Marín G., Marín B.V., Benowitz N.L. Misclassification of smoking status by self-reported cigarette consumption. Am. Rev. Respir. Dis. 1992, 145:53-57.
16. Rainey C.L., Conder P.A., Goodpaster J.V. Chemical characterization of dissolvable tobacco products promoted to reduce harm. J. Agric. Food Chem. 2011, 59:2745-2751.
17. Sakaguchi C., Kakehi A., Minami N., Kikuchi A., Futamura Y. Exposure evaluation of adult male Japanese smokers switched to a heated cigarette in a controlled clinical setting. Regul. Toxicol. Pharmacol. 2014, 69:338-347.
18. Scherer G. Biomonitoring of inhaled complex mixtures-ambient air, diesel exhaust and cigarette smoke. Exp. Toxicol. Pathol. 2005, 57(Suppl. 1):75-110.
19. Scherer G. Carboxyhemoglobin and thiocyanate as biomarkers of Exposure to carbon monoxide and hydrogen cyanide in tobacco smoke. Exp. Toxicol. Pathol. 2006, 58:101-124.
20. Schorp M.K., Tricker A.R., Dempsey R. Reduced exposure evaluation of an electrically heated cigarette smoking system. Part 1: non-clinical and clinical insights. Regul. Toxicol. Pharmacol. 2012, 64(2 Suppl.):S1-10.
21. Vesey C.J., McAllister H., Langford R.M. A safer method for the measurement of plasma thiocyanate. J. Anal. Toxicol. 1999, 23:134-136.
22. Yamasaki E., Ames B.N. Concentration of mutagens from urine by absorption with the nonpolar resin XAD-2: cigarette smokers have mutagenic urine. Proc. Natl. Acad. Sci. U.S.A. 1977, 74:3555-3559.